Resultados de la búsqueda 821-830 of 10084 for isotretinoin
The purpose of this study is to define the recommended dose, safety, tolerability, immunogenicity, and preliminary effectiveness of EO2463 during ...
The purpose of this study is to determine the feasibility of serial cerebrospinal fluid (CSF) assessments to evaluate the pharmacodynamic impact of agents ...
This phase II trials studies how well acalabrutinib with or without obinutuzumab works in treating participants with early-stage chronic lymphocytic leukemia or ...
The purpose of this study is to correlate gut microbiome with specific cancer diagnoses and the clinical response (effectiveness), and adverse effects of cancer ...
Ami TR. Allscripts EPSi. Mayo Clinic. Feb. 23, 2024. Isotretinoin. Facts & Comparisons eAnswers. https://www.wolterskluwercdi.com/facts-comparisons-online.
Averigua por qué el médico te hace análisis de sangre durante el tratamiento oncológico y qué signos y síntomas pueden indicar un recuento bajo de células ...
Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor ...
ES-View All. Acné; Arañas vasculares; Arrugas · Celulitis; Cicatrices; Cicatrices del acné; Imperfecciones de la piel; Manchas seniles (manchas cutáneas) ...
Cholangiocarcinoma (CCA) has key similarities with HCC, therefore, we hypothesize that Sulf1 and Sulf2 may also play roles in promotion of CCA progression.
Albert Lea, Minn., Rochester, Minn., Jacksonville, Fla. The puporse of this trial is to compare less intense hormone therapy and radiation therapy to usual ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?